204 related articles for article (PubMed ID: 31783318)
21. Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal.
Ou S; Xia L; Li R; Wang L; Xia L; Zhou Q; Pan S
Epilepsy Behav; 2018 Nov; 88():295-300. PubMed ID: 30340125
[TBL] [Abstract][Full Text] [Related]
22. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
23. Quantifying the response to antiepileptic drugs: effect of past treatment history.
Schiller Y; Najjar Y
Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
[TBL] [Abstract][Full Text] [Related]
24. Patients' attitude toward AED withdrawal: A survey among individuals who had been seizure-free for over 2 years.
Cvetkovska E; Babunovska M; Kuzmanovski I; Boskovski B; Sazdova-Burneska S; Aleksovski V; Isjanovska R
Epilepsy Behav; 2020 Mar; 104(Pt A):106881. PubMed ID: 31931459
[TBL] [Abstract][Full Text] [Related]
25. Treatment patterns in patients with a new diagnosis of epilepsy and psychiatric comorbidities.
Kalilani L; Friesen D; Murray P
Epilepsy Behav; 2019 Oct; 99():106405. PubMed ID: 31487669
[TBL] [Abstract][Full Text] [Related]
26. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
[TBL] [Abstract][Full Text] [Related]
28. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
Borghs S; Byram L; Chan J; Dedeken P; Logan J; Kiri V; Noack-Rink M; Patsalos PN; Thieffry S
BMC Neurol; 2020 Jan; 20(1):7. PubMed ID: 31914953
[TBL] [Abstract][Full Text] [Related]
29. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs.
Fishman J; Kalilani L; Song Y; Swallow E; Wild I
J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142
[TBL] [Abstract][Full Text] [Related]
30. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Stephen LJ; Wishart A; Brodie MJ
Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
[TBL] [Abstract][Full Text] [Related]
31. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.
Polard E; Nowak E; Happe A; Biraben A; Oger E;
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1161-9. PubMed ID: 26395769
[TBL] [Abstract][Full Text] [Related]
32. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
[TBL] [Abstract][Full Text] [Related]
33. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
Stephen LJ
Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
[TBL] [Abstract][Full Text] [Related]
34. Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States.
Faught E; Laliberté F; Wang Z; Barghout V; Haider B; Lejeune D; Germain G; Choi J; Wagh A; Duh MS
Epilepsia; 2017 Oct; 58(10):1742-1748. PubMed ID: 28741690
[TBL] [Abstract][Full Text] [Related]
35. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications.
Pugh MJ; Vancott AC; Steinman MA; Mortensen EM; Amuan ME; Wang CP; Knoefel JE; Berlowitz DR
J Am Geriatr Soc; 2010 Mar; 58(3):465-71. PubMed ID: 20398114
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30-year cohort study.
Alsfouk BA; Alsfouk AA; Chen Z; Kwan P; Brodie MJ
Epilepsia; 2019 Jun; 60(6):1083-1090. PubMed ID: 31111485
[TBL] [Abstract][Full Text] [Related]
37. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
[TBL] [Abstract][Full Text] [Related]
38. Timing of antiepileptic drug withdrawal in adult epilepsy patients after neocortical surgical resection: a critically appraised topic.
Ziemba KS; Wellik KE; Hoffman-Snyder C; Noe KH; Demaerschalk BM; Wingerchuk DM
Neurologist; 2011 May; 17(3):176-8. PubMed ID: 21532391
[TBL] [Abstract][Full Text] [Related]
39. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy.
Camfield P; Camfield C
Neurology; 2005 Mar; 64(6):973-5. PubMed ID: 15781810
[TBL] [Abstract][Full Text] [Related]
40. Drug treatment in patients with newly diagnosed unprovoked seizures/epilepsy.
Karlsson L; Wettermark B; Tomson T
Epilepsy Res; 2014 Jul; 108(5):902-8. PubMed ID: 24721202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
